Goldman Sachs’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Goldman Sachs’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-691,432	Closed	-$29.1M	–	5995
2023 Q2	$29.1M	Sell	691,432 -141,843	-17%	-$5.74M	0.01%	1532
2023 Q1	$29.7M	Sell	833,275 -3,046,327	-79%	-$111M	0.01%	1453
2022 Q4	$142M	Buy	3,879,602 +3,164,772	+443%	+$125M	0.03%	558
2022 Q3	$33.7M	Buy	714,830 +71,456	+11%	+$4.62M	0.01%	1411
2022 Q2	$46.1M	Sell	643,374 -46,278	-7%	-$3.38M	0.01%	1181
2022 Q1	$55.8M	Buy	689,652 +206,914	+43%	+$17.5M	0.01%	1180
2021 Q4	$49.6M	Sell	482,738 -49,723	-9%	-$4.77M	0.01%	1351
2021 Q3	$46.6M	Buy	532,461 +41,559	+8%	+$3.76M	0.01%	1337
2021 Q2	$43.9M	Sell	490,902 -414,389	-46%	-$35M	0.01%	1373
2021 Q1	$68.7M	Sell	905,291 -34,532	-4%	-$2.6M	0.02%	916
2020 Q4	$64M	Sell	939,823 -455,346	-33%	-$28.4M	0.02%	923
2020 Q3	$74.2M	Buy	1,395,169 +547,813	+65%	+$32.6M	0.02%	740
2020 Q2	$49.4M	Sell	847,356 -456,634	-35%	-$24.5M	0.02%	964
2020 Q1	$51.4M	Sell	1,303,990 -193,225	-13%	-$11.3M	0.02%	841
2019 Q4	$89M	Sell	1,497,215 -91,250	-6%	-$4.91M	0.02%	764
2019 Q3	$84.5M	Sell	1,588,465 -242,246	-13%	-$12.4M	0.02%	765
2019 Q2	$93.5M	Sell	1,830,711 -112,560	-6%	-$5.24M	0.03%	724
2019 Q1	$101M	Sell	1,943,271 -390,027	-17%	-$18.9M	0.03%	665
2018 Q4	$91.8M	Sell	2,333,298 -183,374	-7%	-$8.52M	0.03%	654
2018 Q3	$130M	Buy	2,516,672 +374,956	+18%	+$18.4M	0.03%	602
2018 Q2	$100M	Buy	2,141,716 +1,017,455	+90%	+$42.1M	0.03%	731
2018 Q1	$39.9M	Buy	1,124,261 +699,022	+164%	+$27.4M	0.01%	1347
2017 Q4	$18.5M	Sell	425,239 -154,777	-27%	-$7.23M	﹤0.01%	1995
2017 Q3	$30.3M	Buy	580,016 +279,070	+93%	+$15.6M	0.01%	1657
2017 Q2	$17.6M	Sell	300,946 -296,696	-50%	-$15.4M	﹤0.01%	2033
2017 Q1	$27.4M	Buy	597,642 +417,423	+232%	+$20.8M	0.01%	1679
2016 Q4	$9.48M	Sell	180,219 -161,745	-47%	-$7.83M	﹤0.01%	2512
2016 Q3	$15.2M	Buy	341,964 +103,403	+43%	+$4.48M	﹤0.01%	2108
2016 Q2	$9.1M	Buy	238,561 +167,893	+238%	+$7.38M	﹤0.01%	2388
2016 Q1	$2.91M	Buy	70,668 +56,775	+409%	+$2.34M	﹤0.01%	3166
2015 Q4	$674K	Sell	13,893 -42,413	-75%	-$1.89M	﹤0.01%	4659
2015 Q3	$2.25M	Buy	56,306 +17,998	+47%	+$786K	﹤0.01%	3673
2015 Q2	$1.54M	Buy	38,308 +15,091	+65%	+$521K	﹤0.01%	4118
2015 Q1	$760K	Sell	23,217 -52,646	-69%	-$1.45M	﹤0.01%	4732
2014 Q4	$1.95M	Buy	+75,863	New	+$1.8M	﹤0.01%	3868

Other funds holding SYNH

Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

CFB

Cullen/Frost Bankers San Antonio, Texas $10.1B AUM 29.18% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Goldman Sachs's SYNH Position: Q3 2023 in Review

Goldman Sachs sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 691,432 shares — an estimated $29.1M sold.

Goldman Sachs first reported a position in SYNH in Q4 2014 and held it in 35 quarters. The position peaked at $142M in Q4 2022. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

Goldman Sachs reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
Goldman Sachs sold 691,432 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $29.1M.
Goldman Sachs first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2014 and held it in 35 quarters.
Goldman Sachs's Syneos Health, Inc. Class A Common Stock position peaked at $142M in Q4 2022.
10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Goldman Sachs's 13F filing for Q3 2023, filed 14 Nov 2023.